Fabry‐specific treatment in Australia: time to align eligibility criteria with international best practices

Background Disease‐specific therapy aims to improve symptoms, stabilise current disease and delay progression in patients with Fabry disease. In Australia, treatment access is subject to eligibility criteria initially established in 2004. Patients and their clinicians question why these criteria hav...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Internal medicine journal 2024-06, Vol.54 (6), p.882-890
Hauptverfasser:	Nicholls, Kathleen, Denaro, Charles, Tchan, Michel, Ellaway, Carolyn, Bratkovic, Drago, Campbell, Sheridan, Fookes, Megan, Thomas, Mark
Format:	Artikel
Sprache:	eng
Schlagworte:	access Australia Classification Consensus Eligibility Determination - methods Enzyme Replacement Therapy Fabry disease Fabry Disease - therapy Fabry's disease Female healthcare quality Humans Male migalastat Patient Selection Patients Practice Guidelines as Topic - standards
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!